Home › Squamous Cell Carcinoma › Illinois › Chicago
Squamous Cell Carcinoma clinical trials in Chicago, IL
3 studies for Squamous Cell Carcinoma are looking for participants at sites in and around Chicago (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Lenvatinib and Pembrolizumab to Treat Patients With Anal or Rectum Cancer That Has Gotten Worse After Initial Treatment
RecruitingPhase 2
- University of Chicago Medicine Comprehensive Cancer Center, Chicago
A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma
RecruitingPhase 3
- University of Illinois Cancer Center, Chicago
Dose Finding Study of Zanzalintinib With Pembrolizumab and Cetuximab in Head and Neck SCC
RecruitingPhase 1
- University of Chicago Medicine Comprehensive Cancer Center, Chicago
Squamous Cell Carcinoma trials in other cities
- Pittsburgh, PA10 studies
- Los Angeles, CA8 studies
- Boston, MA8 studies
- Houston, TX7 studies
- New York City, NY7 studies
- Nashville, TN7 studies
- Atlanta, GA5 studies
- Durham, NC4 studies
- Arlington, VA4 studies
- Tampa, FL4 studies
- Washington, DC4 studies
- Queens, NY4 studies
Other studies in Chicago
- Non-Small Cell Lung Cancer61 studies
- Breast Cancer58 studies
- Cancer (all types)51 studies
- Metastatic Cancer45 studies
- Prostate Cancer45 studies
- Obesity41 studies
- Lung Cancer41 studies
- Ovarian Cancer36 studies
- Stroke34 studies
- Colorectal Cancer33 studies
- Heart Failure31 studies
- Overweight28 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.